{"HALLMARK_PANCREAS_BETA_CELLS": 40, "HALLMARK_WNT_BETA_CATENIN_SIGNALING": 42, "HALLMARK_PROTEIN_SECRETION": 96, "HALLMARK_APICAL_SURFACE": 44, "HALLMARK_INTERFERON_ALPHA_RESPONSE": 97, "HALLMARK_PEROXISOME": 104, "HALLMARK_E2F_TARGETS": 200, "HALLMARK_IL6_JAK_STAT3_SIGNALING": 87, "HALLMARK_HEDGEHOG_SIGNALING": 36, "HALLMARK_MITOTIC_SPINDLE": 200, "HALLMARK_XENOBIOTIC_METABOLISM": 200, "HALLMARK_OXIDATIVE_PHOSPHORYLATION": 200, "HALLMARK_IL2_STAT5_SIGNALING": 200, "HALLMARK_INTERFERON_GAMMA_RESPONSE": 200, "HALLMARK_CHOLESTEROL_HOMEOSTASIS": 74, "HALLMARK_UNFOLDED_PROTEIN_RESPONSE": 113, "HALLMARK_ALLOGRAFT_REJECTION": 200, "HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY": 49, "HALLMARK_G2M_CHECKPOINT": 200, "HALLMARK_ESTROGEN_RESPONSE_EARLY": 200, "HALLMARK_TGF_BETA_SIGNALING": 54, "HALLMARK_P53_PATHWAY": 200, "HALLMARK_COAGULATION": 138, "HALLMARK_ANGIOGENESIS": 36, "HALLMARK_INFLAMMATORY_RESPONSE": 200, "HALLMARK_COMPLEMENT": 200, "HALLMARK_FATTY_ACID_METABOLISM": 158, "HALLMARK_MYC_TARGETS_V2": 58, "HALLMARK_ANDROGEN_RESPONSE": 101, "HALLMARK_ADIPOGENESIS": 200, "HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION": 200, "HALLMARK_HYPOXIA": 200, "HALLMARK_MYOGENESIS": 200, "HALLMARK_MTORC1_SIGNALING": 200, "HALLMARK_GLYCOLYSIS": 200, "HALLMARK_SPERMATOGENESIS": 135, "HALLMARK_KRAS_SIGNALING_UP": 200, "HALLMARK_BILE_ACID_METABOLISM": 112, "HALLMARK_DNA_REPAIR": 150, "HALLMARK_TNFA_SIGNALING_VIA_NFKB": 200, "HALLMARK_UV_RESPONSE_DN": 144, "HALLMARK_MYC_TARGETS_V1": 200, "HALLMARK_APICAL_JUNCTION": 200, "HALLMARK_UV_RESPONSE_UP": 158, "HALLMARK_KRAS_SIGNALING_DN": 200, "HALLMARK_NOTCH_SIGNALING": 32, "HALLMARK_HEME_METABOLISM": 200, "HALLMARK_ESTROGEN_RESPONSE_LATE": 200, "HALLMARK_PI3K_AKT_MTOR_SIGNALING": 105, "HALLMARK_APOPTOSIS": 161}